DoD Melanoma, Technology Development Partnership Award
The summary for the DoD Melanoma, Technology Development Partnership Award grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the Dept of the Army USAMRAA, which is the U.S. government agency offering this grant.
DoD Melanoma, Technology Development Partnership Award: With the Technology Development Partnership Award (TDPA), the FY20 MRP encourages investigations into emerging technologies to assist in the detection, diagnosis, prognosis, and ultimately treatment of melanoma. The intent of the TDPA is to foster collaboration between biomedical sciences and physical sciences (e.g., bioengineering, computational science, imaging science, and bioinformatics) and spur progress in the development of computational approaches, bioinformatics, devices, or knowledge based products or outcomes, etc. A “Knowledge Product” is a non-materiel product that addresses an identified need in a melanoma, is based on current evidence and research, aims to transition into medical practice, training, tools, or to support materiel solutions (systems to develop, acquire, provide, and sustain medical solutions and capabilities), and educates or impacts behavior throughout the continuum of care, including primary prevention of negative outcomes. The TDPA is a partnership award with an Initiating Principal Investigator (PI) and a Partnering PI. One PI must be from the biomedical sciences and one PI must be from the physical sciences. The TDPA encourages a cross-disciplinary approach to address research or patient outcome gaps in diagnostics, high risk markers, tumor dormancy, and tumor spread. It should be clear that the project will require both PIs and the project will benefit from each discipline's perspective. Applications should apply a convergent methodology where a physical science approach lends support and enhancement to the understanding of melanoma initiation and progression. The project must clearly respond to the FY20 MRP Challenge Statement. The PI identified as the Initiating PI will be responsible for the majority of the administrative tasks associated with application submission. Both PIs should contribute significantly to the development of the proposed research project, including the Project Narrative, Statement of Work (SOW), and other required components. If recommended for funding, each PI will be named to an individual award within the recipient organization. For individual submission requirements for the Initiating and Partnering PI, refer to Section II.D.2, Content and Form of the Application Submission. The TDPA requires applicants to study one focus area within the melanoma field: bioengineering approaches to address diagnostics, high risk markers, dormancy, and metastasis.
Federal Grant Title: | DoD Melanoma, Technology Development Partnership Award |
Federal Agency Name: | Dept of the Army USAMRAA (DOD-AMRAA) |
Grant Categories: | Science and Technology |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | W81XWH-20-MRP-TDPA |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 12.420 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | September 24th, 2020 |
Original Application Deadline: | September 24th, 2020 |
Posted Date: | April 21st, 2020 |
Creation Date: | April 21st, 2020 |
Archive Date: | October 24th, 2020 |
Total Program Funding: | $20,000,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | 2 |
Cost Sharing or Matching: | No |
Last Updated: | April 21st, 2020 |
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Grant Announcement Contact
- CDMRP Help Desk
Phone: 301-682-5507
Email: [email protected]
CDMRP Help Desk - Similar Government Grants
- • DOD Pancreatic Cancer, Translational Research Partnership Award
- • DOD Pancreatic Cancer, Idea Development Award
- • DOD Pancreatic Cancer, Focused Pilot Award
- • DoD Autism, Discovery Award
- • DoD Tick-Borne Disease, Idea Development Award
- • FY2006 Deployed War Fighter Protection Research Program
- • Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
- • Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
- More Grants from the Dept of the Army USAMRAA
- • DOD Pancreatic Cancer, Translational Research Partnership Award
- • DOD Pancreatic Cancer, Idea Development Award
- • DOD Pancreatic Cancer, Focused Pilot Award
- • Military Health System Research Program Notice of Funding Opportunity